Companies: 10,795·Total market cap: $144.5T
Eli Lilly and Company

Eli Lilly and Company

LLYNYSEHealthcare● Active
$1,131.42
+$6.15(+0.55%)
Market Cap$1.07T
P/E Ratio
52W High$1166.29
52W Low$623.78

Eli Lilly and Company(LLY)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LLY · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$65.18B$45.04B$34.12B$28.54B$28.32B
Cost of Revenue$10.56B$8.42B$7.08B$6.63B$7.31B
Gross Profit$54.62B$36.62B$27.04B$21.91B$21.01B
Gross Margin %(computed)83.79%81.31%79.25%76.77%74.18%
Operating Expenses
R&D Expenses$13.34B$10.99B$9.31B$7.19B$6.93B
G&A Expenses$11.09B$8.13B$6.94B$6.07B$6.14B
Total Operating Expenses$24.92B$19.12B$16.25B$13.26B$13.07B
Operating Income$29.70B$17.50B$10.79B$8.65B$7.93B
Operating Margin %(computed)45.56%38.86%31.61%30.32%28.01%
Interest Income$0.15B$0.18B$0.17B$0.06B$0.03B
Interest Expense$0.80B$0.78B$0.49B$0.33B$0.34B
Income Before Tax$25.73B$12.68B$6.55B$6.81B$6.16B
Income Tax Expense$5.09B$2.09B$1.31B$0.56B$0.57B
Net Income$20.64B$10.59B$5.24B$6.24B$5.58B
Net Margin %(computed)31.66%23.51%15.36%21.88%19.71%
Per Share & EBITDA
EPS (Basic)$23.00$11.76$5.83$6.57$5.85
Wtd Avg Shares0.90B0.90B0.90B0.95B0.95B
EBITDA$27.94B$15.23B$8.57B$8.66B$8.04B
EBITDA Margin %(computed)42.86%33.81%25.11%30.34%28.40%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Eli Lilly and Company

关于Eli Lilly and Company(LLY)损益表

Eli Lilly and Company(LLY)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LLY实现营收$65.18B,毛利润$54.62B(毛利率83.79%),净利润$20.64B(净利率31.66%)。

常见问题

LLY · 4 问

Eli Lilly and Company(LLY)2025财年营收为$65.18B,同比up44.7%。

LLY revenueLLY salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08